Evidence map›Paper›PMID 34264352›Full record

ArticleInternational orthopaedics2021

Capitate shortening osteotomy with or without vascularized bone grafting for the treatment of early stages of Kienböck's disease.

Galal Hegazy, Mahmoud Seddik, Abdel-Hakim Massoud, Rashed Imam, Ehab Alshal, Emad Zayed, Ahmed Darweash

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Galal HegazyOrthopedic Department, Faculty of Medicine, AL-Azhar University, Nasr CityCairo, 11884, Egypt. glalhegazy@azhar.edu.eg.ORCID 0000-0001-9728-2064
Mahmoud SeddikOrthopedic Department, Faculty of Medicine, AL-Azhar University, Nasr CityCairo, 11884, Egypt.
Abdel-Hakim MassoudOrthopedic Department, Faculty of Medicine, AL-Azhar University, Nasr CityCairo, 11884, Egypt.
Rashed ImamOrthopedic Department, Faculty of Medicine, AL-Azhar University, Nasr CityCairo, 11884, Egypt.
Ehab AlshalOrthopedic Department, Faculty of Medicine, AL-Azhar University, Assiut CityAssiut, 71524, Egypt.
Emad ZayedOrthopedic Department, Faculty of Medicine, AL-Azhar University, Nasr CityCairo, 11884, Egypt.
Ahmed DarweashOrthopedic Department, Faculty of Medicine, Suez University, El Salam CitySuez, 43533, Egypt.
Al-Azhar University · EGSuez University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe study evaluates the procedures of capitate shortening osteotomy with or without vascularized bone grafting (VBG) for the treatment of stage II or IIIA Kienböck's disease with neutral ulnar variance.

methodForty-five patients with stage II (n = 21) and IIIA (n = 24) Kienböck's disease were included in the study. Patients were classified into two groups; isolated capitate shortening (ICS) group included 21 patients (stage II [n = 10] and stage IIIA [n = 11]) treated by capitate shortening without VBG of the lunate. Combined capitate shortening (CCS) group includes 24 patients (stage II [n = 11] and stage IIIA [n = 13]) who treated by capitate shortening combined with VBG of the lunate from the dorsal distal radius based on the fourth + fifth extensor compartment artery. All patients were evaluated pre- and post-operative for pain as measured by visual analogue scale score (VAS), range of motion (ROM), grip strength, modified Mayo wrist score (MMWS), lunate height index (LHI) ratio, and carpal height index (CHI) ratio.

resultsThe mean operative time for CCS procedure was 85 min (76 to 120) and for ICS was 58 min (47 to 65). The mean follow-up period for all patients was 33 months (29 to 47). Patients with stage IIIA Kienböck's disease treated by CCS procedure had better post-operative VAS, ROM, grip strength, MMWS, LHI, and CHI ratio than patients treated by ICS procedure. ICS procedure reported 28% failure rate versus 8% for CCS. No differences were found between CCS and ICS procedures in patients with stage II Kienböck's disease in the term of clinical, radiographic outcomes, or failure rate.

conclusionUsing CCS procedure for the treatment of stage IIIA Kienböck's disease (lunate height collapse) with neutral ulnar variance can restore height and dimensions of the collapsed lunate and subsequently improve the final outcomes with lower failure rate. However, in patients with stage II Kienböck's disease (maintained lunate height), no advantages were noticed for CCS over ICS procedure. Lunate height index might be considered a prognostic factor for the treatment outcomes of Kienböck's disease.

Indexed as

Capitate BoneOsteonecrosisBone TransplantationFollow-Up StudiesHumansOsteotomyRadiusRange of Motion, ArticularWrist JointBone graftingCapitate shorteningDistal radiusKienböck’s diseaseLunateVascularized

Identifiers

PMID34264352
OpenAlexW3182363879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.